Fact CheckerSign in

NCT07693985Completed

Multimodal Exercise and Education Program in Metastatic Breast CancerMostrar más líneas

Effects of a Multimodal Community-based Intervention Combining Physical Exercise and Health Education Workshops on Quality of Life in Women With Metastatic Breast Cancer: a Longitudinal Pre-post Study.

Source: ClinicalTrials.gov · Last updated 9 Jul 2026

Brief summary (registry, in English)

This longitudinal pre-post study evaluates the effects of a 12-week community-based multimodal intervention combining supervised physical exercise and health education in women with metastatic breast cancer receiving active systemic treatment. The intervention includes Nordic walking, Tai Chi, and structured health education workshops. The main outcomes are changes in health-related quality of life and cancer-related fatigue, assessed before and after the intervention using validated EORTC questionnaires.Mostrar más líneas

Status (registry)
Completed
Study type
Interventional
Enrollment
37 (actual)
First submitted
29 Jun 2026
Start date
12 Jan 2024
Primary completion date
17 Dec 2025
Lead sponsor
University of Valencia
NCT number
NCT07693985

What you commit to

  • Study type: Interventional
  • Participants enrolled: 37
  • From 12 Jan 2024 to the primary completion date, 17 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Moderate or severe cognitive impairment.
  • Severe psychiatric illness.
  • Sensory impairment preventing participation in the intervention or assessments.
  • Chronic disabling conditions limiting participation in the planned activities.
  • Cardiac or respiratory disease limiting the capacity to perform physical activity.
  • Any other medical condition that, in the opinion of the treating oncologist, contraindicated participation in the program.

Other

  • Unstable bone metastases, according to medical judgment, associated with risk of fragility fracture.

Who the study is looking for

  • Women diagnosed with metastatic breast cancer.
  • Receiving active systemic treatment.
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
  • Able to ambulate independently.
  • Able and willing to participate in the multimodal intervention program.
  • Provided written informed consent.

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Carmen García Gomariz
Coordinator of this site? Confirm its status
ValenciaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.